Please login to the form below

Not currently logged in
Email:
Password:

funding

This page shows the latest funding news and features for those working in and with pharma, biotech and healthcare.

Bayer opens AI-enabled drug discovery center in UK

Bayer opens AI-enabled drug discovery center in UK

The 11 companies are split into two groups. One set of companies will board the growth track, giving them a chance to receive 75, 000 (£65, 000) in funding and the ... Initial project funding and milestone payments are available to companies on the

Latest news

More from news
Approximately 12 fully matching, plus 1,141 partially matching documents found.

Latest Intelligence

  • Rare diseases: redefining medical communications Rare diseases: redefining medical communications

    product. Failure to do this early in the process can lead to difficulties in gaining funding for treatment later. ... Therefore, it is essential that companies engage with all relevant stakeholders early to identify, collect and provide the evidence of

  • European biotech: a new generation of leaders emerges European biotech: a new generation of leaders emerges

    Figures from Silicon Valley Bank (SVB) for 2018 show the funding gap remains huge: the year saw biopharma investments rise to $16.23bn, with the US accounting for nearly $13.5bn ... Instead it is offering funding for “fully integrated private companies

  • A new era in European Parliament: policymakers need to hear from pharma A new era in European Parliament: policymakers need to hear from pharma

    They will soon be asked for their input on highly complex proposals on healthcare technology appraisals, vaccination programmes and priorities for research funding, all of which could have a profound impact

  • The fight for affordable insulin The fight for affordable insulin

    They do a lot of important work, but most patient advocacy organisations take funding from the industry, and there are studies out there which show that this does influence policies.

  • Building Europe’s next breakthrough biotechs Building Europe’s next breakthrough biotechs

    We think that a major reason for this is a lack of sufficient funding and support at the very early stage(s) to enable these technologies to be properly spun-out ... Though seed funding is often available from business angels, friends, family or the

More from intelligence
Approximately 1 fully matching, plus 160 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 12 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 2 fully matching, plus 74 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
JPA Health Communications

JPA Health is an award-winning public relations, marketing and advocacy firm known for sharing our clients’ commitment to making people...

Latest intelligence

eyeforpharma Marketing and Customer Innovation Europe
By Richard Springham...
US Drug pricing
The Golden Goose
Why it’s so hard for the US to curb runaway drug prices...
What is changing in cardiovascular disease care?
Paul Midgley, of Wilmington Healthcare, explores the NHS Long-term Plan’s strategy for tackling cardiovascular disease and what it means for pharma...

Infographics